CCTN - 长效可逆避孕药的临床评估-猫眼课题宝

CCTN - 长效可逆避孕药的临床评估

批准号：

9924402

负责人：

MITCHELL CREININ

金额：

$39.55万

依托单位：

UNIVERSITY OF CALIFORNIA AT DAVIS

依托单位国家：

美国

项目类别：

财政年份：

2015

资助国家：

美国

项目状态：

已结题

起止时间：

2015-09-25 至 2022-09-27

来源：

https://reporter.nih.gov/project-details/9924402

关键词：

Age Attitude Chlamydia Clinical Trials Network Contraceptive Agents Contraceptive History Contraceptive methods Devices Effectiveness Eligibility Determination Enrollment Frequencies Future Gonorrhea Guidelines Gynecology Hemorrhage Implant Incidence Informed Consent Instruction Lead Medical Muscle Cramp National Institute of Child Health and Human Development Pain Pap smear Pattern Pharmaceutical Preparations Pregnancy Pregnancy Tests Procedures Protocols documentation Randomized Randomized Controlled Clinical Trials Recording of previous events Reproductive History Safety Sampling Specific qualifier value Ultrasonography Urine Vaginal Ring Visit Woman contraceptive efficacy demographics follow-up prospective recruit reproductive research clinical testing reversible contraceptive screening side effect standard of care treatment arm

项目摘要

项目成果

MITCHELL CREININ的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

LARC methods include IUDs, implants, or long acting vaginal rings, LARC methods are more effective than daily, weekly or monthly products because they are less prone to user error. IUDs and implants have an effectiveness rate that is the top tier for typical use. In order to evaluate if new LARC products could be effective for contraception, and have a lower incidence of side effects that might lead to discontinuation, a prospective randomized controlled clinical trial will be conducted in the NICHD Contraceptive Clinical Trial Network (CCTN).

期刊论文(0)

专著(0)

科研奖励(0)

会议论文